Head-to-head comparison of the diagnostic accuracy of prostate-specific membrane antigen positron emission tomography and conventional imaging modalities for …

KM Chow, WZ So, HJ Lee, A Lee, DWT Yap… - European urology, 2023 - Elsevier
Context Whether prostate-specific membrane antigen positron emission tomography (PSMA-
PET) should replace conventional imaging modalities (CIM) for initial staging of intermediate …

[HTML][HTML] PSMA theranostics: review of the current status of PSMA-targeted imaging and radioligand therapy

W Jones, K Griffiths, PC Barata, CJ Paller - Cancers, 2020 - mdpi.com
Prostate-specific membrane antigen (PSMA) has been the subject of extensive investigation
in the past two decades as a promising molecular target for prostate cancer (PCa). Its …

[HTML][HTML] Diagnostic performance and safety of positron emission tomography with 18F-rhPSMA-7.3 in patients with newly diagnosed unfavourable intermediate-to very …

DS Surasi, M Eiber, T Maurer, MA Preston, BT Helfand… - European urology, 2023 - Elsevier
Abstract Background Radiohybrid (rh) 18 F-rhPSMA-7.3 is a novel high-affinity prostate-
specific membrane antigen (PSMA)-targeting radiopharmaceutical for prostate cancer (PCa) …

[HTML][HTML] PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review

LJ Petersen, HD Zacho - Cancer Imaging, 2020 - Springer
Background PSMA PET is a promising method for primary lymph node staging in prostate
cancer. However, recent systematic reviews have identified only a limited number of studies …

Histological comparison between predictive value of preoperative 3‐T multiparametric MRI and 68Ga‐PSMA PET/CT scan for pathological outcomes at radical …

A Franklin, WJ Yaxley, S Raveenthiran… - BJU …, 2021 - Wiley Online Library
Objective To evaluate the ability of preoperative multiparametric magnetic resonance
imaging (mpMRI) and a gallium‐68 prostate‐specific membrane antigen positron emission …

[HTML][HTML] Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate …

S Malaspina, M Anttinen, P Taimen, I Jambor… - European Journal of …, 2021 - Springer
Purpose To prospectively compare 18 F-prostate-specific membrane antigen (PSMA)-1007
positron emission tomography (PET)/CT, whole-body magnetic resonance imaging (WBMRI) …

The impact of positron emission tomography imaging and tumor molecular profiling on risk stratification, treatment choice, and oncological outcomes of patients with …

A Sood, AU Kishan, CP Evans, FY Feng… - European Urology …, 2024 - Elsevier
Context The clinical introduction of next-generation imaging methods and molecular
biomarkers (“radiogenomics”) has revolutionized the field of prostate cancer (PCa). While …

[HTML][HTML] Update of PSMA theranostics in prostate cancer: current applications and future trends

C Kaewput, S Vinjamuri - Journal of Clinical Medicine, 2022 - mdpi.com
There is now an increasing trend for targeting cancers to go beyond early diagnosis and
actually improve Progression-Free Survival and Overall Survival. Identifying patients who …

The role of magnetic resonance imaging and positron emission tomography/computed tomography in the primary staging of newly diagnosed prostate cancer: a …

RS Abrams-Pompe, S Fanti, IG Schoots… - European urology …, 2021 - Elsevier
Context Management of newly diagnosed prostate cancer (PCa) is guided in part by
accurate clinical staging. The role of imaging, including magnetic resonance imaging (MRI) …

[HTML][HTML] Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and Multiparametric MRI for Pelvic Lymph Node Staging Prior to Radical Prostatectomy in Patients …

X Wang, Q Wen, H Zhang, B Ji - Frontiers in Oncology, 2021 - frontiersin.org
Purpose To compare the diagnostic performance of 68Ga-PSMA-11 PET/CT and mpMRI for
pelvic lymph node staging prior to radical prostatectomy in prostate cancer (PCa) patients …